AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($399.47 B vs $293.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABBV | MRK |
|---|---|---|
| Market cap | $399.47 B | $293.16 B |
| US-listed rank | #28 | #44 |
| Revenue (latest FY) | $61.16B | $65.01B |
| Net income (latest FY) | $4.23B | $18.25B |
| Net margin | 6.9% | 28.1% |
| P/E (trailing FY) | 94.5 | 16.1 |
| SEC filings | 1,008 | 996 |
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($399.47 B vs $293.16 B).
In their latest fiscal years, AbbVie Inc. reported $61.16B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: AbbVie Inc. and Merck & Co., Inc., or browse the full rankings.